Mirpolyz 100 & 300 100 mg, 300 mg Tablets
PDF Leaflet Revision Date: 06 September 2022
Clinical Summary
Quick overview from the medicine insert
Indication
Management of gout and uric acid-related conditions.
Dosage (summary)
Adults: 100 to 900 mg daily, titrated based on urate levels.
Special Populations
- Renal impairment
- Hepatic impairment
- Children under 15 years
Pregnancy & Breastfeeding
Safety in pregnancy not established; contraindicated in lactation.
Key Drug Interactions
- Azathioprine
- Mercaptopurine
- Cyclophosphamide
- Theophylline
- Chlorpropamide
Contraindications
- Hypersensitivity to allopurinol
- Severe hepatic or renal disorder
- Acute gout attack
- Lactating mothers
- Children (except malignancy)
Common side effects
- Rash
- Nausea
- Diarrhoea
- Headache
- Drowsiness
Counselling Points
- Take after meals for better tolerance
- Maintain hydration
- Monitor for skin reactions
- Avoid during acute gout attacks
Serious warnings
- Serious allergic reactions
- Exacerbation of gout attacks
- Renal impairment precautions
Important Disclaimer
The Mirpolyz 100 & 300 100 mg, 300 mg Tablets professional information leaflet below is the property of Dezzo Trading 392 and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
